Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis

Published:2015-09-03 Issue:9 Volume:42 Page:1082-1092
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Jharap B.¹,Sandborn W. J.²,Reinisch W.³⁴,D'Haens G.⁵,Robinson A. M.⁶,Wang W.⁶,Huang B.⁶,Lazar A.⁷,Thakkar R. B.⁶,Colombel J.-F.¹

Affiliation:

1. The Dr Henry D. Janowitz Division of Gastroenterology; Icahn School of Medicine at Mount Sinai; New York NY USA

2. Inflammatory Bowel Disease Center; Division of Gastroenterology; University of California San Diego; La Jolla CA USA

3. Department of Gastroenterology; McMaster University; Hamilton ON Canada

4. Department of Gastroenterology and Hepatology; Medical University of Vienna; Vienna Austria

5. Department of Gastroenterology; Academic Medical Center; Amsterdam The Netherlands

6. AbbVie Inc.; North Chicago IL USA

7. AbbVie Deutschland GmbH & Co. KG; Ludwigshafen Germany

Funder

AbbVie

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13387/fullpdf

Reference34 articles.

1. Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus;Reinisch;J Crohns Colitis,2012

2. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?;D'Haens;Am J Gastroenterol,2011

3. Importance of mucosal healing in ulcerative colitis;Lichtenstein;Inflamm Bowel Dis,2010

4. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis;Colombel;Gastroenterology,2011

5. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience;Laharie;Aliment Pharmacol Ther,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study;European Journal of Clinical Investigation;2024-07-09

2. Disease clearance in ulcerative colitis: A new therapeutic target for the future;World Journal of Gastroenterology;2024-04-07

3. Endoscopic healing is associated with a reduced risk of biologic treatment failure in patients with ulcerative colitis;Scientific Reports;2024-01-03

4. Bibliometric Analysis of Research Trends in Ulcerative Colitis Treatments: 2003-2023;2024

5. Gut microbial signatures in clinically stable ulcerative colitis according to the mucosal state and associated symptoms;Journal of Gastroenterology and Hepatology;2023-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3